Skip to main content
Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
1.555
+0.135 (9.51%)
At close: Apr 24, 2025, 4:00 PM
1.510
-0.045 (-2.89%)
After-hours: Apr 24, 2025, 4:38 PM EDT

Biodexa Pharmaceuticals Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Biodexa Pharmaceuticals.

Analyst Consensus: n/a
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

There are currently no analyst ratings available for Biodexa Pharmaceuticals.

Recommendation Trends

Rating Feb '24
Strong Buy 0
Buy 0
Hold 0
Sell 0
Strong Sell 0
Total 0

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Aydin Huseynov
Ladenburg Thalmann
 Ladenburg Thalmann
Strong Buy
Initiates
$200
 Strong Buy Initiates $200 +12,761.74% Feb 8, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.61
from -11.57
EPS Next Year
-2.94
from -2.61
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
 343.00K578.00K699.00K381.00K---3.07K
Revenue Growth
 -49.11%68.51%20.93%-45.49%----
EPS
 ----224.13-11.57-2.61-2.94-2.30
EPS Growth
 --------
Forward PE
 --------
No. Analysts
 -----333
Financial currency is GBP. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High n/a n/a 3,157
Avg n/a n/a 3,067
Low n/a n/a 2,947

Revenue Growth

Revenue Growth 202520262027
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202520262027
High -2.69 -3.03 -2.37
Avg -2.61 -2.94 -2.30
Low -2.51 -2.82 -2.21

EPS Growth

EPS Growth 202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.